ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 186 filers reported holding ARCUS BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $424,554 | -14.0% | 23,276 | -2.5% | 0.01% | -26.3% |
Q4 2022 | $493,507 | -35.0% | 23,864 | -18.1% | 0.02% | -24.0% |
Q3 2022 | $759,000 | -6.9% | 29,153 | -9.4% | 0.02% | +4.2% |
Q2 2022 | $815,000 | -11.3% | 32,184 | +10.5% | 0.02% | 0.0% |
Q1 2022 | $919,000 | -6.4% | 29,125 | +20.0% | 0.02% | -7.7% |
Q4 2021 | $982,000 | -51.9% | 24,270 | -58.6% | 0.03% | -58.1% |
Q3 2021 | $2,043,000 | +18.5% | 58,581 | -6.7% | 0.06% | +19.2% |
Q2 2021 | $1,724,000 | +11.4% | 62,765 | +13.8% | 0.05% | 0.0% |
Q1 2021 | $1,548,000 | +7.8% | 55,144 | -0.3% | 0.05% | -10.3% |
Q4 2020 | $1,436,000 | +86.3% | 55,334 | +23.0% | 0.06% | +52.6% |
Q3 2020 | $771,000 | -35.3% | 44,978 | -6.7% | 0.04% | -39.7% |
Q2 2020 | $1,192,000 | -41.6% | 48,200 | -67.1% | 0.06% | -21.2% |
Q3 2018 | $2,041,000 | +6.8% | 146,384 | -6.2% | 0.08% | +5.3% |
Q2 2018 | $1,911,000 | – | 156,139 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |